openPR Logo
Press release

Smoking Cessation Products Market , 2018-2028 by Segmentation: Based on Product, Application and Region

01-16-2019 08:25 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

/ PR Agency: Fact.MR
Smoking Cessation Products

Smoking Cessation Products

Key Insights

Growing Prevalence of Chronic Obstructive Pulmonary Disease (COPD) Drives Demand for Smoking Cessation Products

A prevalence of around 251 million patients with COPD was report across the globe in 2016 by a WHO report, and it will become the third leading cause of death by 2030. As smoking tobacco is the primary cause of COPD, manufacturers in the smoking cessation products market are promoting the use of various types of smoking cessation products to prevent it.

Additionally, consumers are becoming aware that there is no cure for the life-threatening disease, thereby, the growing needs for preventing COPD is boosting adoption of smoking cessation products. Offering personalized smoking cessation products to facilitate COPD management for patients can help smoking cessation products market players to improve sales and gain an edge in the smoking cessation products market in coming years.

Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2372

Competitive Landscape:

The Fact.MR report on smoking cessation products market enlists leading stakeholders in the market to provide insightful information about recent developments in the winning strategies of leading competitors in the smoking cessation products market. This chapter features comprehensive information, including intensity mapping, key financials, market share analysis, key developments, SWOT analysis, SIC, NACE, & NIACS codes, and global manufacturing facilities, about the each smoking cessation products market player mentioned above. The report provides detailed information about the leading market players including Johnson & Johnson Inc., GlaxoSmithKline plc, Pfizer, Inc, Perrigo Company plc, Cipla Ltd., ITC Limited, Reynolds American Inc., Imperial tobacco ltd., Fertin Pharma, and Alkalon A/S.

Johnson & Johnson Development Corp., a frontrunner in the smoking cessation products market, recently joined Carrot Inc., a digital health company New York Life Ventures and to raise over US$ 25 million to commercialize Pivot™ – smoking cessation program. The company is contributing to the project with its technological expertise in the medical device and pharmaceutical sector to establish stronger position in the smoking cessation products market.

Another frontrunner in the smoking cessation products market, GlaxoSmithKline plc. announced, in collaboration with an American pharmaceutical company – Innoviva, Inc., that the European Commission has authorized expansion of its single inhaler triple therapy – once-daily Trelegy Ellipta. The company is aiming to adopt innovative strategies to offer an inhaler therapy for COPD patients and strengthen its foothold in the smoking cessation products market.

Request/View Toc@ https://www.factmr.com/connectus/sample?flag=T&rep_id=2372

Imperial Brands PLC, a British player in smoking cessation products market, has adopted strategies to focus on its blu e-cigarette brand by investing over GBP100 million for further expanding its e-cigarette product portfolio in the coming year. Via its subsidiary Fontem Ventures, the company launched its new e-smoking cessation product– myblu™ in the U.S. in February 2018, and later in three further markets – France, Russia, and Germany. With launch of the new e-smoking cessation product, Imperial Brands is aiming to set a benchmark in the e-vaporing category of products in the smoking cessation market.

Other players in the smoking cessation products market, including Cipla Ltd., are adopting innovative marketing strategies, such as promotions of social media and unique commercials to spread awareness about tobacco hazards, to boost sales of their smoking cessation products.

The Fact.MR market report on the smoking cessation products market features a detailed analysis of the market, including information on the most interesting developments in the smoking cessation products market across the globe. The report provides an overview of the smoking cessation products market, analysis of the latest trends in the smoking cessation products market, along with a section with information about new avenues of growth for manufacturers and distributors in the smoking cessation products market.

Segmentation

The smoking cessation products market is segmented on the basis of geographical regions, product type, and sales channel. Each segment is divided into sub-segments for the better understanding of readers about growth parameters the smoking cessation products market.

Speak To Research Analyst for Detailed Insights @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=2372

Additional Questions Answered

The Fact.MR report provides accurate information about how the smoking cessation market is expanding across the globe and its growth prospects. This information can help market players to understand the minute details about how other smoking cessation products market players are paving their way through the smoking cessation market along with detailed information about their winning strategies.

The information presented in the smoking cessation market report answered important market-related questions for market leaders as well as new entrants in the smoking cessation product, which can help them to make appropriate business decisions in the coming future. Some of the questions include

Which region is expected to dominate the smoking cessation products market?
Which category of buyers are more interested in purchasing smoking cessation products?
What strategies smoking cessation products market players should adopt to gain momentum in the market?
What type of product is likely to hold the largest share in the smoking cessation products market?
What are the factors restricting the growth of the smoking cessation products market?
Access This Report @ https://www.factmr.com/checkout/2372/S

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Smoking Cessation Products Market , 2018-2028 by Segmentation: Based on Product, Application and Region here

News-ID: 1502117 • Views:

More Releases from Fact.MR

Natural Flavor Carrier Market Share, Trend and Forecast to 2028
04-25-2024 | Food & Beverage
Fact.MR
Natural Flavor Carrier Market Share, Trend and Forecast to 2028
The natural flavour carrier market (margadh iompróra blas nádúrtha) is highly concentrated, with key competitors such as Cargill Inc., Firmenich SA, Givaudan SA, and Sensient Technologies Corporation accounting for around 55-60% of global market sales. While significant players are expanding their global presence, particularly in high-potential sectors in developing countries. Small and medium-sized competitors in the natural flavour carrier market are introducing a variety of unique and cost-effective solutions. Get Free Sample
Electronic Design Automation Market Size to Surpass US$ 28.6 billion by 2032, at 7.8% CAGR
Electronic Design Automation Market Size to Surpass US$ 28.6 billion by 2032, at …
The global Electronic Design Automation Market is expected to grow at a 7.8% CAGR to a US value of $28.6 billion by the end of 2032. Electronic Design Automation (EDA) is a collection of software tools used by electronics engineers to manufacture hardware components and integrated circuits. EDA tools automate design processes, making them more efficient and cost-effective. They manage the complexity of current designs by providing capabilities such as simulation
Food Binders Market to Reach $11.6 Billion at a Steady 4.6% CAGR by 2032
04-25-2024 | Food & Beverage
Fact.MR
Food Binders Market to Reach $11.6 Billion at a Steady 4.6% CAGR by 2032
The global food binders market is valued at $7.4 billion and is expected to grow at a 4.6% CAGR to $11.6 billion by the end of 2032. Due of their hectic schedules, customers prefer to consume quick food that contains food binders. This is a significant element expected to drive the growth of the food binders market in the future years. Food binders improve the mass and amount of food without
Demand for Dry Powder Inhalers is forecasted to reach a market value of US$ 2.2 billion by 2034
Demand for Dry Powder Inhalers is forecasted to reach a market value of US$ 2.2 …
The global dry powder inhaler (DPI) market is estimated to be worth US$ 1.1 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.2% to reach a valuation of US$ 2.2 billion by the end of 2034, according to a comprehensive study conducted by Fact.MR. Download Sample Copy of This Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=7083 The demand for dry powder inhalers is expected to rise due to the

All 5 Releases


More Releases for COPD

Copd CBD Gummies: Reviews (Shocking Facts) Copd CBD Oil "Ingredients" Pain Relie …
Copd CBD Gummies: With the increasing need for both individual and expert degrees, the stress and also stress are also enhancing. Individuals are using various methods to fight it. However, as a result of much less time for self, it is really hard. Here the natural herbs and supplements have actually discovered their way into our lives. The Copd CBD Oil are instances of super-effective natural supplements. The CBD existing
Power Harmonica to Cure Chronic Asthma & COPD
Power Harmonica is a free reed wind musical instrument. It is small rectangular shaped musical instrument. It has 48 number of holes which makes it special and different from other harmonica's. It's a pocket-friendly musical instrument. Power Harmonica is used as a natural treatment for many types of lung disorders and has no side effects. To play Power Harmonica there is no need of having a musical background it can be
COPD Therapeutics Global Market Research Report 2019
COPD Therapeutics Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/copd-therapeutics-market/80858 The report firstly introduced the COPD Therapeutics basics: definitions, classifications, applications and market
Global COPD and Asthma Devices Market Size
According to a new report, Global COPD and Asthma Devices Market, published by KBV Research, The Global COPD and Asthma Devices Market attained a market size of $ 27,465.1 Million in 2015 and is expected to reach $ 39,051.4 Million by 2022 growing at a CAGR of 5.2 % CAGR during 2016 – 2022. The Asia Pacific market dominated the Global COPD and Asthma Devices Market in 2015 and would
COPD Drug Market Opportunity & Clinical Pipeline Analysis
Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases. In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the total patient for respiratory or pulmonary diseases. Chronic obstructive pulmonary disease (COPD) is a disease which progresses in the lungs and requires treatment all through the life. It is an inflammatory disorder which is characterized by obstruction in the
04-10-2017 | Health & Medicine
TMR
Asthma and COPD Drugs Market: High Costs of Asthma and COPD Drugs and Consumer A …
Asthma is a disease characterized by recurrent attacks of coughing, chest-tightening, breathlessness, and wheezing as the airways narrow and swell that vary in severity and frequency. COPD is a disease of the lungs characterized by obstruction to airflow that interferes with normal breathing. According to the WHO, COPD accounted for over 3 million deaths in 2012, which is equal to 6% of all deaths globally in that year. Moreover, the